#bacteria

A study in mice found that engineered "bacterial biosensors” could detect DNA shed by colorectal cancer tumors.

These bacteria can promote the development of colorectal cancer by damaging DNA and hindering the body’s immune system.

Balyn Zaro, PhD, studies genetic differences in the innate immune system and how they can impact the effectiveness of the meds we take.

Two studies at the intersection of cancer and microbiome research explore how bacteria help tumors grow and spread.

Researchers found that shutting down the effects of the abnormal collagen made treatments for pancreatic cancer more effective.

Cancer drugs called immune checkpoint inhibitors can cause itching and painful skin rashes. But what triggers these side effects?

Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.

Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.

This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.

New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics.

We take a closer look at the use of antibiotics, and why they aren’t prescribed for colds.

The innovative approach, which eliminated tumors, may lead to more effective therapies for people with cancer.

Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer.

Many experts believe that because they can detect colon cancer, the benefit of colonoscopies outweighs the risk of infection.

Moxetumomab pasudotox “offers an option for patients with relapsed or refractory hairy cell leukemia that avoids additional chemotherapy.”

Study highlights the importance of foreign microbes in the prevention of disease throughout the body.